A Comparative Study Between Anterior Glenoid Block With Sub-omohyoid Suprascapular Block Versus Interscalene Block in Shoulder Arthroscopy
NCT ID: NCT06609590
Last Updated: 2025-07-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
60 participants
INTERVENTIONAL
2024-09-25
2025-03-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Group A: Patients will receive Anterior glenoid block combined with suprascapular nerve block.
Group B: Patients will receive conventional interscalene block.
In group A, the patient will be supine for anterior glenoid block.
The suprascapular nerve will be identified as it branch off from the superior trunk and will be traced until it courses beneath the inferior belly of the omohyoid muscle.
In group B, interscalene brachial plexus block will be performed.
The primary outcomes will be as follows: (1) 11-point (0-10) numeric rating scale (NRS) pain score immediately before surgery starts and after surgery; (2) degree of preserved diaphragmatic function (DPDF): the ratio of postoperative to pre-block (baseline) diaphragmatic excursion amplitude will be assessed in the holding area using a curvilinear probe (Sono Site, Transportable fuji M-turbo ultrasound system).;(3) degree of preserved handgrip strength (DPHS): the ratio of postoperative to pre-block (baseline) handgrip strength (the maximal force patients exerted when instructed to squeeze the dynamometer handles as tightly as feasible). Measurements will be done before surgery, immediately postoperative, 4, 8, and 24 hours postoperatively.
And (4) Recording of the complications which are: Hematoma, nerve injury, allergy to any of the used drugs.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Pain Managment in Chronic Shoulder Pain
NCT06106490
Ultrasound-guided Interscalene Block Versus Infraspinatus-Teres Minor Plane Block in Shoulder Arthroscopy
NCT07016386
Corticosteroid Injection Versus Nerve Block
NCT06735027
Interscalene and Combined Supra Scapular and Axillary Nerve Blocks in Rotator Cuff Repair
NCT01730573
Comparison of the Effects Suprascapular Nerve Block and Intra-articular Shoulder Injection
NCT05909462
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group A
Patients will receive Anterior glenoid block combined with suprascapular nerve block.
Glenoid nerve block combined with Sub-omohyoid Anterior Suprascapular nerve Block
Ultrasound guided anterior glenoid nerve block combined with Sub-omohyoid Anterior Suprascapular nerve Block
Group B
The patients will Interscalene brachial plexus block.
Interscalene brachial plexus block
Ultrasound guided interscalene brachial plexus block
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Glenoid nerve block combined with Sub-omohyoid Anterior Suprascapular nerve Block
Ultrasound guided anterior glenoid nerve block combined with Sub-omohyoid Anterior Suprascapular nerve Block
Interscalene brachial plexus block
Ultrasound guided interscalene brachial plexus block
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Aged 18 to 65 years.
3. Both sexes.
4. Patients scheduled for shoulder arthroscopy.
Exclusion Criteria
2. ASA physical status III or more.
3. Patients with known allergy to any of the study drugs.
4. Infection at the site of injection.
5. Patients with history of cardiovascular disease.
6. Patients with renal disease.
7. Patients with hepatic disease.
8. Patients with neuromuscular disease.
9. Presence of any coagulopathy.
10. Chronic opioid, gabapentin or pregabalin use.
11. Patients with history of any psychiatric disorder.
18 Years
65 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ain Shams University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
riham fathy galal
Lecturer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ain shams university hospitals
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FAMSU R143/2024
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.